Lipid effects of hormone replacement therapy with sequential transdermal 17-Beta-estradiol and oral dydrogesterone

Obstetrics and Gynecology

Volumn 95, Issue 1, 2000, Pages 111-114

  Nieto, Jose J ^a   Cogswell, Diana ^b   Jesinger, Diana ^c   Hardiman, Paul ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c Solvay Healthcare Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; DYDROGESTERONE; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION;

ADULT; APOLIPOPROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYDROGESTERONE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES;

EID: 0033988415     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00476-7     Document Type: Article

References (17)

1. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. JAMA. 265:1991;1861-1867.
2. Ross R.K., Paganini-Hill A., Mack T.M., Arthur M., Henderson B.E. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet. 1:1981;858-860.
3. Stampfer M.J., Willett W.C., Colditz G.A., Rosner B., Speizer H.E., Hemekens C.H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 313:1985;1044-1049.
4. Crook D., Stevenson Y.C., Whitehead M.I. Estrogen replacement therapy and cardiovascular disease Effects on plasma lipid risk markers . Schwartz D.P. Hormonal replacement. 1992;132-170 Williams & Wilkins, Baltimore, Maryland.
5. Judd H. Efficacy of transdermal estradiol. Am J Obstet Gynecol. 156:1987;1326-1331.
6. Crook D., Stevenson S.C. Transdermal hormone replacement therapy, serum lipids and lipoprotein. Br J Clin Pract. 86:(suppl):1996;17-21.
7. Crook D., Cust M.P., Gangar K.F., Worthington M., Hillard T.C., Stevenson J.C., et al. Comparison of transdermal and oral estrogen-progestin replacement therapy Effects on serum lipids and lipoproteins . Am J Obstet Gynecol. 166:1992;950-955.
8. Adami S., Rossini M., Zainberian N., Bertoldo F., Dorizzi R., Lo Cascio V. Long-term effects of transdermal and oral estrogens on serum lipids in postmenopausal women. Maturitas. 17:1993;191-196.
9. Mattsson L., Sansioe G., von Shoultz B., Uvebrant M., Wiklund I. Transdermally administered oestradiol combined with oral medroxyprogesterone acetate The effects of lipoprotein metabolism in postmenopausal women . Br J Obstet Gynaecol. 100:1993;450-453.
10. Siddle N.C., Jesinger D.K., Whitehead M.I., Turner P., Lewis B., Prescott P. Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added dydrogesterone. Br J Obstet Gynaecol. 97:1990;1093-1100.
11. Crook D., Godsland I.F., Hull S., Stevenson J.C. Hormone replacement therapy with dydrogesterone and 17B-oestradiol Effects on serum lipoproteins and glucose tolerance during 24 month follow up . Br J Obstet Gynaecol. 104:1997;298-304.
12. Van der Mooren M.J., Dewacker P.N.M., Thomas C.M.G., Rolland R. Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study. Eur J Obstet Gynecol Reprod Biol. 47:1992;153-160.
13. Gelfand M.M., Fugere P., Bissonnette F., Wiita B., Yang J.M., Lorrain J., et al. Conjugated oestrogens combined with sequential dydrogesterone or medroxyprogesterone acetate in postmenopausal women Effects on lipoproteins, glucose tolerance, endometrial histology and bleeding . Menopause. 4:1997;10-18.
14. Warnick G., Albers J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J Lipid Res. 19:1978;65-76.
15. Gidez L., Miller G., Burstoin M., Slage S., Elder H. Separation and quantitation of subclasses of human plasma high-density lipoproteins by a simple precipitation procedure. J Lipid Res. 23:1982;1206-1223.
16. Mount J., Kearney E., Rosseneu M., Slavin B. Immunoturbidimetric assays for serum apolipoproteins A1 & B using cobas biocentrifugal analyser. J Clin Pathol. 41:1988;471-474.
17. Crook D. Postmenopausal hormone replacement therapy, lipoprotein metabolism and coronary heart disease. J Cardiovasc Pharmacol. 28:(suppl):1996;5:540-5:545.